Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Soliris (eculizumab)
pCPA File Number:
21270
Negotiation Status:
Active Negotiation
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Alexion Pharma GMBH
CADTH Project Number:
SR0640-000
pCPA Engagement Letter Issued:
2021-03-02
Negotiation Process Concluded:
Not Applicable